Alternative treatment regimens and predictive markers of interferon monotherapy failure in patients with chronic hepatitis C

被引：0
|
作者：
Diculescu, MI
Iacob, SC
Iacob, RI
Oproiu, A
机构：
[1] Fundeni Gastroenterol & Hepatol Ctr, Bucharest, Romania
[2] Carol Davila Univ Med & Pharm, Bucharest, Romania
来源：
JOURNAL OF HEPATOLOGY | 2001年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：144 / 144
页数：1
相关论文
共 50 条
  • [21] Treatment of chronic hepatitis C in patients who failed interferon monotherapy: Effects of higher doses of interferon and ribavirin combination therapy
    Shiffman, ML
    Hofmann, CM
    Gabbay, J
    Luketic, VA
    Sterling, RK
    Sanyal, AJ
    Contos, MJ
    Ryan, MJ
    Yoshida, C
    Rustgi, V
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (10): : 2928 - 2935
  • [22] FACTORS PREDICTIVE OF THE RESPONSE TO INTERFERON IN PATIENTS WITH CHRONIC HEPATITIS-C
    SERFATY, L
    GIRAL, P
    LORIA, A
    ANDREANI, T
    LEGENDRE, C
    POUPON, R
    JOURNAL OF HEPATOLOGY, 1994, 21 (01) : 12 - 17
  • [23] Interferon alpha with ribavirin for the treatment of chronic hepatitis C in non-responders or relapsers to interferon monotherapy
    Moreno-Monteagudo, JA
    Fernandez-Bermejo, M
    Garcia-Buey, L
    Sanz, P
    Iacono, LO
    Garcia-Monzon, C
    Borque, MJ
    Moreno-Otero, R
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1998, 12 (08) : 717 - 723
  • [24] Efficacy and safety of pegylated interferon as monotherapy for treatment of hepatitis C in hemodialysis patients
    Sikole, Aleksandar
    Dzekova, Pavlina
    Nikolov, Igor
    Selja, Nexhmi
    Zabzun, Mustafa
    Muharemi, Sheriat
    Asani, Arben
    Amitov, Vili
    Selim, Gjulsen
    Gelev, Saso
    Gaseva, Magdalena
    Ivanovski, Ljubomir
    Grunevska, Violeta
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 182 - 183
  • [25] Treatment of hepatitis C in hemodialysis patients with pegylated interferon α-2a as monotherapy
    Sikole, Aleksandar
    Dzekova, Pavlina
    Selja, Nexhmi
    Gaseva, Magdalena
    Nikolov, Igor G.
    Zabzun, Mustafa
    Muharemi, Sheriat
    Asani, Arben
    Amitov, Vili
    Mena, Sami
    Grunevska, Violeta
    Ivanovski, Ljubomir
    Polenakovic, Momir
    RENAL FAILURE, 2007, 29 (08) : 961 - 966
  • [26] SYSTEMATIC REVIEW OF NON-INTERFERON BASED REGIMENS FOR CHRONIC HEPATITIS C TREATMENT
    Aggarwal, S.
    VALUE IN HEALTH, 2011, 14 (07) : A267 - A267
  • [27] SYSTEMATIC REVIEW OF NON-INTERFERON BASED REGIMENS FOR CHRONIC HEPATITIS C TREATMENT
    Aggarwal, S.
    VALUE IN HEALTH, 2012, 15 (07) : A385 - A385
  • [28] Combination treatment of interferon alpha-2b and ribavirin in comparison to interferon monotherapy in treatment of chronic hepatitis C genotype 4 patients
    El-Zayadi, A
    Selim, O
    Haddad, S
    Simmonds, P
    Hamdy, H
    Badran, HM
    Shawky, S
    ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1999, 31 (06): : 472 - 475
  • [29] The significance of interferon and ribavirin combination therapy followed by interferon monotherapy for patients with chronic hepatitis C in Japan
    Hiramatsu, N
    Kasahara, A
    Nakanishi, F
    Toyama, T
    Tsujii, M
    Tsuji, S
    Kanto, T
    Takehara, T
    Kato, M
    Yoshihara, H
    Naito, M
    Katayama, K
    Hijioka, T
    Hagiwara, H
    Kubota, S
    Oshita, M
    Meren, H
    Masuzawa, M
    Haruna, Y
    Mita, E
    Suzuki, K
    Hayashi, N
    HEPATOLOGY RESEARCH, 2004, 29 (03) : 142 - 147
  • [30] Efficacy and safety of consensus interferon monotherapy for chronic hepatitis C
    Matsushita, Masahiro
    Kobayashi, Yoshimasa
    Nagasawa, Masamichi
    Takehira, Yasunori
    Tsugiki, Minoru
    Tamakoshi, Katsutoshi
    Nakajima, Takeyuki
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S154 - S154
12345